BriaCell Therapeutics Corp.
BCTX
$3.06
$0.093.03%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.80M | 29.90M | 10.18M | 17.87M | 12.46M |
| Total Receivables | -- | -- | -- | -- | 2.32M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.59M | 2.28M | 1.17M | 2.06M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.39M | 32.18M | 11.35M | 19.93M | 14.79M |
|
|
|||||
| Total Current Assets | 25.39M | 32.18M | 11.35M | 19.93M | 14.79M |
| Net Property, Plant & Equipment | 349.00K | 251.10K | 274.00K | 296.80K | 319.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 173.10K | 176.90K | 180.70K | 184.50K | 188.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 405.10K | 405.10K | 717.50K | 717.50K | 1.21M |
| Total Assets | 27.07M | 33.59M | 13.08M | 21.65M | 17.00M |
|
|
|||||
| Total Accounts Payable | 2.17M | 1.88M | 2.13M | 3.28M | 3.28M |
| Total Accrued Expenses | 1.42M | 1.31M | 1.19M | 694.30K | 1.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.59M | 3.19M | 3.32M | 3.98M | 4.33M |
|
|
|||||
| Total Current Liabilities | 3.59M | 3.19M | 3.32M | 3.98M | 4.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 71.90K | 195.10K | 406.90K | 337.70K | 730.00K |
| Total Liabilities | 3.66M | 3.38M | 3.72M | 4.32M | 5.06M |
|
|
|||||
| Common Stock & APIC | 117.12M | 117.12M | 101.74M | 101.74M | 94.02M |
| Retained Earnings | -134.34M | -127.17M | -119.95M | -111.76M | -103.66M |
| Treasury Stock & Other | 41.28M | 40.97M | 28.19M | 27.90M | 22.06M |
| Total Common Equity | 24.06M | 30.92M | 9.98M | 17.88M | 12.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.06M | 30.92M | 9.98M | 17.88M | 12.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -649.10K | -702.60K | -627.60K | -546.80K | -474.10K |
| Total Equity | 23.41M | 30.21M | 9.35M | 17.33M | 11.94M |
|
|
|||||